Trump’s Medicare Drug Pricing Rule Shrinks From $11.9 Billion to $440 Million: How Pharma Deals Changed the Equation
The Trump administration has finalized a major Medicare drug-pricing experiment that was originally presented as a potentially multibillion-dollar effort to bring the price of certain medicines in the United States closer to what patients pay in other wealthy countries. But by the time the policy reached its final form, the projected savings had fallen dramatically. Medicare actuaries now estimat…
